GEN treatment led to re-expression of DKK1 in SW480 and HCT-15 cell lines, whereas mRNA levels were not affected in other colon cancer cell lines, especially those with extensive DKK1 promoter methylation (RKO, SW48, DLD-1). This evidence concerns the gene DKK1 and malignant colon neoplasm.